Zimmer Biomet Holdings, Inc. and Monogram Technologies Inc. have agreed to a $177 million acquisition deal, with Zimmer Biomet acquiring all outstanding shares of Monogram. This move will create a comprehensive portfolio of orthopedic robotics and navigation technologies, enhancing Zimmer Biomet’s offerings. Monogram’s innovative technologies, including semi- and fully autonomous robotic systems, are expected to revolutionize orthopedic surgery. The acquisition is projected to be neutral to adjusted earnings per share in 2025-2027 and accretive thereafter, contributing to revenue growth starting in 2027. The deal is set to close later this year, pending regulatory approvals and other customary conditions.

Read more at GlobeNewswire: Zimmer Biomet Announces Definitive Agreement to Acquire